Marketing-authorisation holder
Pharma Mar S.A.
18 medicines in 5 countries, as authorisation holder, manufacturer and marketer.
Medicines
Every medicine in the registers under its name, current ones first.
18 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| YONDELISPolvere per concentrato per soluzione per infusione | Trabectedin | Italy | Authorised | |
| Yondelis | Trabectedin | EU (EMA) | Authorised | 2007 |
| Yondelis 0.25 mg, poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Trabectedin | Netherlands | Authorised | 2007 |
| YONDELIS 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION0,25 mg · Polvo para concentrado para solución para perfusión | Trabectedin | Spain | Authorised | 2026 |
| YONDELIS 0,25 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION0,25 mg · Polvo para concentrado para solución para perfusión | Trabectedin | Spain | Marketed | 2007 |
| Yondelis 1 mg, poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Trabectedin | Netherlands | Authorised | 2007 |
| YONDELIS 1 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION1 mg · Polvo para concentrado para solución para perfusión | Trabectedin | Spain | Marketed | 2007 |
| YONDELIS 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION1 mg · Polvo para concentrado para solución para perfusión | Trabectedin | Spain | Authorised | 2026 |
| Zepzelca | Lurbinectedin | EU (EMA) | Authorised | 2026 |
| ZEPZELCAPolvere per concentrato per soluzione per infusione | Lurbinectedin | Italy | Authorised | |
| ZEPZELCA 2 mg poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Lurbinectedin | Netherlands | Authorised | 2026 |
| ZEPZELCA 2 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION2 mg · Polvo para concentrado para solución para perfusión | Lurbinectedin | Spain | Authorised | 2026 |
| ZEPZELCA 4 mg poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Lurbinectedin | Netherlands | Authorised | 2026 |
| ZEPZELCA 4 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION4 mg · Polvo para concentrado para solución para perfusión | Lurbinectedin | Spain | Authorised | 2026 |
| Aplidin | Plitidepsin | EU (EMA) | Refused | |
| Yondelis | Trabectedin | EU (EMA) | Refused | |
| YONDELIS 0,25mg0,25mg · Pulb. pt.conc. pt.sol. perf. | Trabectedin | Romania | unknown | |
| YONDELIS 1mg1mg · Pulb. pt.conc. pt.sol. perf. | Trabectedin | Romania | unknown |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 6 | 6 | 0 | CompaniesAll medicines |
| European Union (EMA) | 4 | 2 | 2 | CompaniesAll medicines |
| Netherlands | 4 | 4 | 0 | CompaniesAll medicines |
| Italy | 2 | 2 | 0 | CompaniesAll medicines |
| Romania | 2 | 0 | 2 | CompaniesAll medicines |
Also in the registers of Brazil, France, United Kingdom
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Antineoplastic agentsAntineoplastic and immunomodulating agents · ATC L01C
- Antineoplastic agentsAntineoplastic and immunomodulating agents · ATC L01X
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- pharma mar
- pharma mar s a
- pharma mar sa
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
All 12 sources
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 18
- Countries
- 5
- Roles
- Authorisation holder, manufacturer and marketer